- Home
- HVT vs INBX Comparison
HVT vs INBX Comparison
Compare HVT & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HVT
- INBX
- Stock Information
- Founded
- HVT 1885
- INBX 2010
- Country
- HVT United States
- INBX United States
- Employees
- HVT N/A
- INBX N/A
- Industry
- HVT Other Specialty Stores
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- HVT Consumer Discretionary
- INBX Health Care
- Exchange
- HVT Nasdaq
- INBX Nasdaq
- Market Cap
- HVT 329.5M
- INBX 345.8M
- IPO Year
- HVT N/A
- INBX 2020
- Fundamental
- Price
- HVT $23.39
- INBX $26.55
- Analyst Decision
- HVT
- INBX Hold
- Analyst Count
- HVT 0
- INBX 2
- Target Price
- HVT N/A
- INBX N/A
- AVG Volume (30 Days)
- HVT 105.0K
- INBX 112.9K
- Earning Date
- HVT 10-29-2025
- INBX 11-13-2025
- Dividend Yield
- HVT 5.47%
- INBX N/A
- EPS Growth
- HVT N/A
- INBX N/A
- EPS
- HVT 1.17
- INBX N/A
- Revenue
- HVT $722,858,000.00
- INBX $1,400,000.00
- Revenue This Year
- HVT $3.69
- INBX N/A
- Revenue Next Year
- HVT $8.33
- INBX N/A
- P/E Ratio
- HVT $19.96
- INBX N/A
- Revenue Growth
- HVT N/A
- INBX N/A
- 52 Week Low
- HVT $17.01
- INBX $10.81
- 52 Week High
- HVT $28.53
- INBX $30.23
- Technical
- Relative Strength Index (RSI)
- HVT 54.82
- INBX 53.66
- Support Level
- HVT $22.66
- INBX $26.19
- Resistance Level
- HVT $24.34
- INBX $28.86
- Average True Range (ATR)
- HVT 0.69
- INBX 1.34
- MACD
- HVT -0.06
- INBX -0.39
- Stochastic Oscillator
- HVT 53.86
- INBX 13.00
About HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.